Salta al contenuto principale
Ricerc@Sapienza
Toggle navigation
Home
Login
Home
Persone
vitaliana.desanctis@uniroma1.it
Vitaliana De Sanctis
Professore Associato
Struttura:
DIPARTIMENTO DI SCIENZE MEDICO-CHIRURGICHE E DI MEDICINA TRASLAZIONALE
E-mail:
vitaliana.desanctis@uniroma1.it
Pagina istituzionale corsi di laurea
Curriculum Sapienza
Pubblicazioni
Titolo
Pubblicato in
Anno
Prevalence, characteristics, and treatment of fatigue in oncological cancer patients in Italy. a cross-sectional study of the Italian Network for Supportive Care in Cancer (NICSO)
SUPPORTIVE CARE IN CANCER
2019
The point of pain in head and neck cancer
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
2019
Intensity modulated radiation therapy and oral mucosa sparing in Head and neck cancer patients. A systematic review on behalf of Italian Association of Radiation Oncology – Head and neck working group
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
2019
Lactobacillus brevis CD2 for Prevention of Oral Mucositis in Patients with Head and Neck Tumors. A multicentric randomized study
ANTICANCER RESEARCH
2019
HAPPY - Humanity Assurance Protocol in interventional radiotheraPY (brachytherapy) - An AIRO Interventional Radiotherapy Study Group project
JOURNAL OF CONTEMPORARY BRACHYTHERAPY
2019
Radiotherapy in metastatic castration resistant prostate cancer patients with oligo-progression during abiraterone-enzalutamide treatment. A mono-institutional experience
RADIATION ONCOLOGY
2019
Long term results of single high dose Stereotactic Body Radiotherapy in the treatment of primary lung tumors
SCIENTIFIC REPORTS
2019
Current state of interventional radiotherapy (brachytherapy) education in Italy. Results of the INTERACTS survey
JOURNAL OF CONTEMPORARY BRACHYTHERAPY
2019
Orbital radiotherapy plus concomitant steroids in moderate-to-severe graves’ ophthalmopathy. Good results after long-term follow-up
INTERNATIONAL JOURNAL OF ENDOCRINOLOGY AND METABOLISM
2019
Locally advanced inoperable primary or recurrent non-small cell lung cancer treated with 4-week hypofractionated radiation therapy (3 Gy/fraction)
LA RADIOLOGIA MEDICA
2019
Inoperable early-stage primary and early recurrent non-small cell lung cancer: outcomes of a mono-institutional experience using a moderate hypofractionated schedule
LA RADIOLOGIA MEDICA
2019
Diffusion magnetic resonance in cervical carcinoma: The role of apparent diffusion coefficient in the evaluation of treatment response
EUROPEAN JOURNAL OF GYNAECOLOGICAL ONCOLOGY
2019
Moderate Hypofractionation in Patients with Low-risk Prostate Cancer: Long-term Outcomes
ANTICANCER RESEARCH
2018
30 Gy single dose stereotactic body radiation therapy (SBRT). Report on outcome in a large series of patients with lung oligometastatic disease
LUNG CANCER
2018
Single nucleotide polymorphism of gstp1 and pathological complete response in locally advanced rectal cancer patients treated with neoadjuvant concomitant radiochemotherapy
RADIATION ONCOLOGY JOURNAL
2018
Re-irradiation in lung disease by SBRT. A retrospective, single institutional study
RADIATION ONCOLOGY
2018
Oligoprogression during Abiraterone therapy treated with radiotherapy in mCRPC patients.
RADIOTHERAPY AND ONCOLOGY
2018
Critical decision-making in radiotherapy for early stage breast cancer in a neo-adjuvant treatment era
EXPERT REVIEW OF ANTICANCER THERAPY
2017
Second cancer incidence in primary mediastinal B-cell lymphoma treated with methotrexate with leucovorin rescue, doxorubicin, cyclophosphamide, vincristine, prednisone, and bleomycin regimen with or without rituximab and mediastinal radiotherapy. results from a monoinstitutional cohort analysis of long-term survivors
HEMATOLOGICAL ONCOLOGY
2017
Secondary malignant neoplasms, progression-free survival and overall survival in patients treated for Hodgkin lymphoma: a systematic review and meta-analysis of randomized clinical trials
HAEMATOLOGICA
2017
« prima
< precedente
1
2
3
4
seguente ›
ultima »
Progetti di Ricerca
Ruolo del Regorafenib come opzione terapeutica di II linea nelle recidive di glioblastoma: valutazione dei benefici nei pazienti già sottoposti a trattamento radioterapico e chemioterapico con temozolomide.
Impatto della moderna radioterapia sulla sopravvivenza dei pazienti con diagnosi di linfoma (Hodgkin e non Hodgkin) diagnosticati nella Regione Lazio dal 2013 al 2017: un modello epidemiologico real-life.
© Università degli Studi di Roma "La Sapienza" - Piazzale Aldo Moro 5, 00185 Roma